StockWatch
·
Biotechnology: Pharmaceutical Preparations
Quarterly ResultApr 22, 2026, 04:07 PM

Johnson & Johnson Files Q1 2026 10-Q Report

AI Summary

Johnson & Johnson submitted its Quarterly Report on Form 10-Q for the fiscal quarter ended March 29, 2026. The filing confirms the company's status as a large accelerated filer and includes its consolidated financial statements. As of April 17, 2026, the company reported 2,407,216,971 shares of common stock outstanding.

Key Highlights

  • Filed Form 10-Q for quarter ended March 29, 2026.
  • Confirmed status as a large accelerated filer.
  • 2,407,216,971 common shares outstanding on April 17, 2026.